Live Breaking News & Updates on அல்லாத ஹாட்ஜ்கின் லிம்போமா|Page 3
Stay updated with breaking news from அல்லாத ஹாட்ஜ்கின் லிம்போமா. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RESILIENCE project aims to reduce the burden of cardiovascular disease in cancer survivors Cancer patients are a vulnerable population prone to develop cardiovascular complications. Among other factors, some anticancer therapies can induce adverse cardiovascular effects. Every year, more than 3 million Europeans receive anthracyclines alone or in combination with other anticancer agents. Anthracyclines are a frequently prescribed anticancer agent that can induce an irreversible toxic effect on the heart may lead to chronic heart failure in ≈5% of the cases. It is estimated that in Europe the prevalence of chronic heart failure secondary to cancer therapy-related cardiotoxicity is ≈1 million people. The trade-off between cancer and chronic heart failure is a massive psychological burden. For healthcare systems, the growing incidence of chronic heart failure has devastating consequences. ....
European Society of Cardiology Madrid, 30 June 2021. Cancer patients are a vulnerable population prone to develop cardiovascular complications. Among other factors, some anticancer therapies can induce adverse cardiovascular effects. Every year, more than 3 million Europeans receive anthracyclines alone or in combination with other anticancer agents. Anthracyclines are a frequently prescribed anticancer agent that can induce an irreversible toxic effect on the heart may lead to chronic heart failure in ≈5% of the cases. It is estimated that in Europe the prevalence of chronic heart failure secondary to cancer therapy-related cardiotoxicity is ≈1 million people. The trade-off between cancer and chronic heart failure is a massive psychological burden. For healthcare systems, the growing incidence of chronic heart failure has devastating consequences. ....
Bayer: US judge rejects Roundup cancer lawsuits plan The German chemical giant may now consider pulling the weedkiller from sale, but maintains that Roundup s main ingredient glyphosate is safe. Bayer will review the future of glyphosate-based weedkillers in the US market US district judge Vincent Chhabria on Wednesday rejected a $2 billion (€1.64 billion) plan set up by German firm Bayer to settle future lawsuits over its controversial Roundup weed killer product. Thousands of Roundup users have claimed the product gave them Non-Hodgkin Lymphoma (NHL), a type of blood cancer. What did the judge say about the plan? Chhabria said parts of the plan are clearly unreasonable and claimed the proposal could not be salvaged by mere tweaks. ....
US judge rejects future Roundup cancer suits deal | Bangladesh Sangbad Sangstha (BSS) bssnews.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bssnews.net Daily Mail and Mail on Sunday newspapers.
US judge rejects future Roundup cancer suits deal timesofmalta.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from timesofmalta.com Daily Mail and Mail on Sunday newspapers.